Ultrasound Assessment of Changes in Nails in Psoriasis and Psoriatic Arthritis

Table 1

Age and clinical characteristic of the patients studied.

	Ps (n=38)	PsA (n=31)	Control (n=30)	p
male/female	20/18	15/16	14/16
Age (years)	48.4± 9.1	49.7± 10.8	49.4 ± 12.7	ns
Ps duration (years)	17.8±10.9	19.3±6.6	-	ns
PsA duration (years)	-	7.8±7.1	-	-
DAS 28	-	3.3 ± 0.6	-	-
PASI	6.2±3.8	4.7±3.7	-	0.034
mNAPSI	21.9±14.9	20.3±15.2	-	ns
ESR	13.9±6.6	25.7±10.2	-	0.017
CRP (mg/dl)	2.7±2.4	9.4±4.1	-	<0.001
TJC	-	2.8±1.4	-	-
SJC	-	2.3±0.6	-	-
DMARD therapy	17/38	27/31	-

Results are presented as numbers or mean values and standard deviations (SD).
Ps: psoriasis, PsA: psoriatic arthritis, DAS: disease activity score, PASI: psoriasis area severity index, mNAPSI: modified nail psoriasis severity index, ESR: erythrocyte sedimentation rate, CRP: C-reactive protein, TJC: tender joint count, SJC: swollen joint count, and DMARD: disease-modifying antirheumatic drug.